Science Explorer Interactive view Map
Topic · Dermatology

Cutaneous lymphoproliferative disorders research

Cutaneous lymphoproliferative disorders research is a research topic within Dermatology. Science Explorer counts 20k research works in it since 1950. 12.5% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the classification, staging, treatment, and prognosis of cutaneous lymphomas, with a specific emphasis on mycosis fungoides and Sézary syndrome. It includes discussions on the WHO-EORTC classification, survival outcomes, prognostic factors, and various treatment options such as bexarotene and denileukin diftitox. The cluster also addresses the incidence patterns, genomic landscape, and molecular profiling of cutaneous T-cell lymphomas.

  • Cutaneous Lymphomas
  • Mycosis Fungoides
  • Sézary Syndrome
  • EORTC Classification
  • T-Cell Lymphoma
  • CD30+ Lymphoproliferative Disorders
  • Primary Cutaneous Lymphomas
  • Bexarotene Treatment
  • Prognostic Factors
  • Clinical End Points
Research works
20k
fractional, since 1950
In the world top 10%
2.5k
per year above
Top-10% rate
12.5%
share of its works in the world top 10%
Growth, 2013–17 → 2018–22
+35%
the tick is no change

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Cutaneous lymphoproliferative disorders research research?

By volume, the United States and China publish the most (1.1k and 400 works in 2022–2025).

By volume, 2022–2025

  1. 1 United States 1.1k works
  2. 2 China 400 works
  3. 3 India 229 works
  4. 4 Italy 176 works
  5. 5 Germany 175 works
  6. 6 France 171 works
  7. 7 Japan 156 works
  8. 8 Brazil 154 works
  9. 9 Spain 139 works
  10. 10 United Kingdom 114 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 39.5%China: 14.1%India: 8.1%Italy: 6.2%6 others listed: 32.0%40%largest
United States1,119 · 39.5%China400 · 14.1%India229 · 8.1%Italy176 · 6.2%6 others listed908 · 32.0%

Shares of the rows listed above, not of the whole node.

Which institutions lead Cutaneous lymphoproliferative disorders research research?

By volume in 2022–2025, The University of Texas MD Anderson Cancer Center publishes the most Cutaneous lymphoproliferative disorders research research, followed by Memorial Sloan Kettering Cancer Center and Chinese Academy of Medical Sciences & Peking Union Medical College.

By volume, 2022–2025

  1. 1 The University of Texas MD Anderson Cancer CenterUnited States 41 works
  2. 2 Memorial Sloan Kettering Cancer CenterUnited States 22 works
  3. 3 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 18 works
  4. 4 University of PennsylvaniaUnited States 16 works
  5. 5 Mayo Clinic in ArizonaUnited States 15 works
  6. 6 Stanford UniversityUnited States 14 works
  7. 7 Yale UniversityUnited States 14 works
  8. 8 Harvard UniversityUnited States 13 works
  9. 9 Cornell UniversityUnited States 13 works
  10. 10 InsermFrance 13 works

Who are the leading researchers in Cutaneous lymphoproliferative disorders research?

The most-cited researchers publishing on Cutaneous lymphoproliferative disorders research include Caroline Robert, Thomas Schwarz and Elı́as Campo.

  1. 1 Caroline Robert France 3.3k citations
  2. 2 Thomas Schwarz United States 3.1k citations
  3. 3 Elı́as Campo Spain 3k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

Where is Cutaneous lymphoproliferative disorders research research done?

The largest centres of Cutaneous lymphoproliferative disorders research research in 2022–2025 are New York (United States), Beijing (China), Houston (United States) and Paris (France). Among places with at least 20 works in it, it is an unusually large share of all research in Houston.

Largest cities, 2022–2025

  1. 1 New York United States 81 works
  2. 2 Beijing China 81 works
  3. 3 Houston United States 58 works
  4. 4 Paris France 58 works
  5. 5 Philadelphia United States 53 works
  6. 6 Boston United States 43 works
  7. 7 São Paulo Brazil 39 works
  8. 8 Shanghai China 37 works
  9. 9 London United Kingdom 36 works
  10. 10 Tokyo Japan 35 works

Where it is the local speciality

  1. HoustonUS · 58.0 works6.3×
← less than its size predicts1×more →

Location quotient: how much more of its research is in Cutaneous lymphoproliferative disorders research than the world average.

See Cutaneous lymphoproliferative disorders research on the map

Where is the best place to study Cutaneous lymphoproliferative disorders research?

Among universities, judged by research, Thomas Jefferson University, University of Miami and University of Pennsylvania score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%10%20%mean 13.2%fractional works in this node (log) →share in the world top 10% →Thomas Jefferson University: 12, 8.2%University of Miami: 12, 18.1%University of Pennsylvania: 16, 13.8%Medical University of Vienna: 8, 13.0%Icahn School of Medicine at Mount Sinai: 12, 11.8%Medical University of Warsaw: 10, 0.8%Cornell University: 13, 14.4%University of Bologna: 8, 22.6%Harvard University: 13, 15.5%Stanford University: 14, 13.8%University of MiamiUniversity of Pennsy…Medical University o…Thomas Jefferson Uni…
above the meannear itbelow it

One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.

#UniversityScoreTop 10%SpecialisationWorksGrowth
1 Thomas Jefferson UniversityUnited States 57.78.2%16.8×12 +247.3%
2 University of MiamiUnited States 55.718.1%6.5×12 +128.5%
3 University of PennsylvaniaUnited States 46.113.8%4.9×16 +73.9%
4 Medical University of ViennaAustria 45.013.0%7.4×8 -7.6%
5 Icahn School of Medicine at Mount SinaiUnited States 44.211.8%6.5×12 +63.9%
6 Medical University of WarsawPoland 43.30.8%12.0×10 +163.5%
7 Cornell UniversityUnited States 43.114.4%3.5×13 +103.8%
8 University of BolognaItaly 43.022.6%2.9×8 +37.3%
9 Harvard UniversityUnited States 42.615.5%2.9×13 +45.6%
10 Stanford UniversityUnited States 39.713.8%3.2×14 +56.1%

Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.

Is Cutaneous lymphoproliferative disorders research research growing?

Output in 2018–2022 was 35% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Cutaneous lymphoproliferative disorders research.

19801990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.